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Objective: Overweight and obesity are globally increasing risk factors for diseases in the 
context of metabolic syndrome. A randomized controlled trial was conducted to investigate 
whether there are any existing differences between two lifestyle intervention strategies with 
respect to weight reduction after 1 year.
Subjects and methods: A total of 166 subjects with a body mass index of 28–35 kg/m2 were 
enrolled in this trial at seven study centers; 109 were randomly allocated to the intervention 
group (comprehensive lifestyle modification program: web-based Individual Health Management 
[IHM]) with 3-month reduction phase plus 9-month maintenance phase, and 57 were allocated 
to the control group (written information with advice for healthy food habits: usual care [UC]). 
Body weight, waist circumference, blood pressure, laboratory findings, and bioimpedance 
analysis used to determine body composition were measured at baseline and after 3, 6, 9, and 
12 months. The primary outcome parameter was body weight at month 12 compared to baseline.
Results: With respect to baseline status there were no statistically significant differences between 
the groups. Based on the intent-to-treat population, body weight showed a mean decrease of 
8.7 kg (SD 6.1) in the intervention group (IHM) and 4.2 kg (SD 5) in the control group (UC) at 
month 12. This statistically significant difference (P<0.001) was confirmed by various sensitivity 
analyses. Body mass index, waist circumference, high-density lipid cholesterol, body fat, and 
the ratio of fat and body cell mass improved to a significantly higher degree in the IHM group.
Conclusion: IHM proved to be superior to UC in weight reduction after 1 year. With a mean 
loss of about 10% of the baseline weight, a clinically high relevant risk reduction for cardio-
metabolic diseases is achievable.
Keywords: Individual Health Management, IHM, overweight, obesity, prevention, lifestyle 
modification
Background
Overweight and obesity are a rising challenge for health care worldwide. Between 
1975 and 2014 there was an increase in the global age-standardized mean body mass 
index (BMI) in men from 21.7 to 24.2 and in women from 22.1 to 24.4.1 In developed 
countries such as the US, the figures are markedly higher. Approximately two-thirds 
of adults are overweight (BMI of 25–29.9) or obese (BMI ≥30).2,3
Obesity is associated with many comorbid conditions that have major implications 
on longevity, quality of life, and health-care costs.4,5 It could be shown that a strong 
and linear association exists between BMI (>20) and the risk of developing type 2 
diabetes, hypertension, cardiovascular disease, and other chronic diseases in both men 
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and women.6 A very recent analysis revealed for European 
countries that even in moderate forms of obesity, all-cause 
mortality was distinctly elevated: BMI 27.5–30 (hazard ratio 
1.21) and BMI 30–35 (hazard ratio 1.52).3 Obesity has been 
proposed by the American College of Cardiology/American 
Heart Association and Task Force on Practice Guidelines to 
be regarded as a “disease” requiring treatment.7
Prevention and treatment of obesity is a multidisci-
plinary approach involving comprehensive strategies of 
psychotherapeutic elements, different types of diet resulting 
in an energy deficit, and behavior modification supporting 
changes in diet and exercise in everyday life.8,9 Enhanced 
lifestyle counseling has proved to be superior to usual care 
with respect to weight reduction.10 Compared to minimal 
or no intervention, it can be shown that self-management 
plus exercise prevented weight increase in patients with 
cardiometabolic disease.11 Although there is a wide range 
of different popular commercial diets available, weight-loss 
programs having their efficacy scientifically evaluated are 
still rare.12,13 Further, long-term adherence to such lifestyle 
changes is usually low.14
We developed an intervention program called Individual 
Health Management (IHM), which is designed to promote 
changes across multiple health behaviors, simultaneously 
aiming for participation of healthy and ill people, in order 
to enhance individual responsibility, self-determination, 
and health literacy. Self-management supporting the par-
ticipants to optimize physiological skills and psychosocial 
competencies is considered the core element of the interven-
tion. It comprises areas such as physical activity, nutrition, 
self-efficacy, and social support, and follows an educational 
concept of blended learning.15
The primary objective of this study was to examine 
whether the IHM intervention strategy was superior to a 
control condition (usual care [UC]) with respect to weight 
reduction at month 12 in overweight persons (BMI 25–30) 
or those with grade 1 obesity (BMI 30–35). Since a BMI of 
25–30 is not consistently associated with increased mortal-
ity,4 we set the lower threshold for BMI to 28, resulting in 
a target range of 28–35. Further objectives of the tailored 
lifestyle self-management intervention (TALENT) study are 
the comparative analysis of secondary outcome parameters 
such as BMI, waist circumference, and laboratory findings.
Subjects and methods
Study design
This study was a multicenter randomized controlled trial 
comprising six study centers located in different health resorts 
all over Bavaria, and complemented by the outpatient unit 
of the Competence Centre for Complementary Medicine 
and Naturopathy at Klinikum Rechts der Isar, Munich. The 
study centers were affiliated to local private practices of 
general practitioners, which are pooled into a centrally coor-
dinated network of health promotion called IHM-Campus. 
Study duration for each participant was 12 months, with 
five sequential examinations at equal intervals of 3 months 
(baseline at month 0, and after 3, 6, 9, and 12 months). The 
study was supervised by a professional institution with 
acknowledged expertise in supervision of clinical trials of 
all kinds (Munich Study Centre, Technical University of 
Munich), including central indoor monitoring and on-site 
visits at the participating study centers.
The study was registered in advance at German 
Clinical Trials Register Freiburg (DRKS, file number 
DRKS00006736, date registered September 20, 2014). 
Ethical approval for this study was obtained from the ethical 
review board of the medical faculty of the Technical Univer-
sity of Munich (file number 97/14). All procedures performed 
in studies involving human participants were in accordance 
with the ethical standards of the institutional and/or national 
research committee and with the 1964 Helsinki Declaration 
and its later amendments or comparable ethical standards. 
Written informed consent was obtained from all individual 
participants included in the study.
Recruitment and participants
As a result of advertisements in local media or local action 
days with the slogan “obesity”, 271 interested persons con-
tacted the local IHM teams for a provisional check of the 
feasibility for the study between October 2014 and February 
2015. All persons who apparently complied with the require-
ments of the study were invited to a personal appointment 
with the trial physician to obtain full information and to 
undergo a comprehensive examination of the criteria for 
inclusion and exclusion.
Participants of both sexes aged 18–67 years with moderate 
overweight defined as BMI 28–35 were included in the study. 
Written informed consent was mandatory. Participants were 
not included if one of the following exclusion criteria was 
present: not legally competent, insufficient skills in  German 
language, no private access to the Internet, already known 
pregnancy, known psychiatric disease, including eating disor-
der or addiction, known diseases of the eyes, known diabetes 
type 1 or 2, hypertension > grade I (systolic blood pressure 
≥160 mmHg or diastolic blood pressure ≥100 mmHg) with/
without medication, known heart disease, known gastric or 
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109 allocated to IHM intervention:
• received false control
  intervention: n=1
• not meeting inclusion criteria: n=49
• exclusion criteria: n=24
• declined to participate: n=27
• exceeded number of participants: n=8
* multiple reasons possible
105 excluded because of:*
• received IHM intervention: n=111
17 dropouts before:
• month 3: n=10
• month 6: n=3
• month 9: n=3
• month 12: n=1
Reasons:
• exclusion criterion: n=2
• too effortful: n=9
• significant life event: n=5
• other/not specified: n=1
With imputation of missing values
at month 12:
• as randomized: n=109
• as treated: n=111
Without imputation:
• as random/per protocol: n=82
• as treated: n=94
With imputation of missing values
at month 12:
• as randomized: n=57
• as treated: n=55
Without imputation:
• as random/per protocol: n=36
• as treated: n=45
10 dropouts before:
• month 3: n=9
• month 6: n=1
• month 9: n=0
• month 12: n=0
Reasons:
• exclusion criterion: n=1
• considered not effective: n=4
• significant life event: n=1
• other/not specified: n=4
57 allocated to UC intervention:
• received false IHM
  intervention: n=3
• received UC intervention: n=55
271 assessed for eligibility
166 randomized (2:1)
Allocation
Premature
discontinuation
Analysis
Enrollment
Figure 1 Consort flowchart showing the design of the study.
Abbreviations: IHM, Individual Health Management; UC, usual care.
duodenal ulcers, diseases of the liver or kidneys that do not 
allow an increased intake of proteins, disease-related impair-
ments hampering certain elements of the lifestyle program, 
or therapeutic conditions not compatible with lifestyle 
modifications. According to the inclusion and exclusion cri-
teria, 105 subjects were ineligible to be included in the study. 
The results of recruitment and enrollment of study participants 
are depicted in the consort study flowchart (Figure 1).
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Randomization
One hundred and sixty-six eligible participants were ran-
domized immediately after formal inclusion in the study. 
To enhance the willingness for study participation, we 
preferred a randomization ratio of 2:1: 109 subjects were 
allocated to the intervention group (IHM) and 57 to the con-
trol group (UC). Randomization and allocation envelopes 
were prepared by an independent statistician at the Institute 
for Medical Statistics and Epidemiology at the Technical 
University of Munich. The trial physicians were instructed 
to open the sealed envelopes in a strictly sequential order 
of enrollment and to disclose the allocated treatment arm 
to the study participant.
Interventions
The study compared two intervention arms – IHM and UC.
IHM group
The IHM lifestyle program, with an overall duration of 
12 months, comprises two phases: 1) the first 3 months 
(reduction phase) include 3 full-day “introduction days” 
plus 10 2-hour weekly training sessions; and 2) during 
the following 9 months (maintenance phase), participants 
practice lifestyle modifications by themselves, supported 
by lifestyle counseling via telephone or email provided by 
trained IHM coaches. At 3-month intervals, they meet for a 
full-day refresher training session at the study center (Figure 
2). The program encompasses access to a web-based health 
portal (www.viterio.de), providing detailed advice and 
instructions with respect to food, exercise, and relaxation. 
Furthermore, this tool allows personalized feedback con-
trol by written reports and graphics of the progress made. 
IHM was implemented as a “blended learning concept”, 
with a combination of group interventions (group size of 
roughly 12), single face-to-face counseling, and an indi-
vidual online portal. All training sessions were performed in 
the local study centers. Details of the intervention concept 
and realization are described elsewhere.15 With respect to 
the food component of the comprehensive lifestyle program, 
all participants were offered three different strategies for 
free choice: 1) calorie restriction day(s) (per week, 1 regu-
lar day, 5 waiver days, 1 calorie restriction day with <900 
kcal plus fasting <500 kcal during week 7); 2) intermittent 
“fasting” (5 regular days, 2 serial calorie restriction days 
with <600 kcal for men and <500 kcal for women); and 3) 
meal replacement (1 regular day, 5 waiver days, one food 
restriction day with meal replacement <900 kcal plus meal 
replacement in week 7). All three strategies have proved to 
be successful in previous pilot groups.
UC group
This was an active control intervention that reflected com-
mon practice in UC with standard advice from a doctor. A 
leaflet containing 10 acknowledged rules for healthy food and 
physical exercise according to the German Nutrition Society 
was handed to the participants.
Outcomes
Body weight, height, waist circumference, blood pressure, 
and heart rates were measured by certified IHM coaches 
at each of the five examination visits. The teams were 
trained to perform the examinations in a standardized way 
(eg, subjects wearing light clothes and no shoes, with use 
of calibrated scales for measuring weight). Weight and 
waist circumference were measured twice and average 
values used in the analysis. On visits at months 0, 3, and 
Figure 2 Schematic course of IHM in weight reduction with study examination visits embedded. Visits embedded (white bars). Introduction days (gray lined bars), 10 × 2-hour 
after-work sessions (gray bars) including self-monitoring , physical activity , nutrition  and stress management packages , and four quarterly refresh meetings (black 
bars).
Abbreviation: IHM, Individual Health Management.
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12, blood samples were taken after overnight fasting in 
order to analyze glucose, serum lipids, and triglycerides 
as part of a standard laboratory examination. All other 
parameters were used for safety reasons. Body composi-
tion, which determines body fat in relation to muscle mass, 
was measured by bioimpedance analysis. All centers were 
equipped with a bioelectrical impedance analyzer (Forana; 
Helios, Frankfurt, Germany [Tethys software version 3.2]). 
At baseline examination, sociodemographic data such as 
education, employment status, and smoking and drinking 
habits were documented. The occurrence of adverse events 
(AEs) was captured systematically at each physical exami-
nation following the baseline test.
Data analysis and statistical methods
Weight reduction at month 12 was chosen a priori as the 
primary outcome variable to be used for hypothesis testing. 
Additionally, a 7.5% weight reduction at month 12 compared 
to baseline value was considered a responder and analyzed 
separately. Intermediate weight measures at months 3, 6, and 
9 were analyzed secondarily.
The estimation of sample size was based on the assump-
tion of a mean reduction in body weight after 12 months of 
6 kg under IHM and of 3 kg under UC conditions. Data from 
the literature suggest a common standard deviation of 6 kg 
for change in weight. Therefore, the sample size for the t-test 
for independent groups (α=0.05, two-sided, power 80%) was 
estimated as 98 in one group and 49 in the second (alloca-
tion ratio 2:1). Taking into account an expected dropout rate 
of 10%, a total sample size of 160 participants was deemed 
appropriate.
Based on the intent-to-treat (ITT) population, the primary 
outcome (change in body weight [Δ
month 0–month 12
]) was tested 
using a general linear model with the grouping factors “inter-
vention” and “study center”, including the covariate baseline 
body weight. A 5% level of significance (two-sided) was 
applied. In cases with missing data for weight at month 12 
(dropouts), a conservative imputation technique was applied. 
Based on the available data for weight at months 0 and 12, 
a linear regression equation was computed for each of the 
two intervention groups. Missing data in the intervention 
group were estimated by the terms of the regression from 
the control group and vice versa.
For additional sensitivity analyses, the imputation tech-
nique was modified in terms of a “realistic” imputation of 
missing data, meaning that missing data in one group were 
replaced by estimates derived from the regression of exactly 
this group. A further criterion for sensitivity analyses was 
to distinguish the ITT group from those subjects passing 
through the study “per protocol”. Subjects were considered 
per protocol if 1) there existed no premature termination of 
the study, 2) there was no missing control examination, and 
3) they were treated as randomized. Participants in the IHM 
group additionally had to adhere sufficiently to the interven-
tion program, which means that they had to have attended at 
least 7 of the 10 group sessions during the first 3 months and 
missed not more than one refresher meeting at months 3–12.
Secondary end points were analyzed and compared by 
group as treated, without imputation of missing data. Dif-
ferences with respect to baseline values and changes from 
month 0 to 12 between the two intervention groups were 
assessed by t-tests for independent samples. For differences 
between values at months 0 and 12, t-tests for paired samples 
were applied in each of the two groups. All statistical tests 
were performed two-sided, with a significance level of 5%, 
and in the sense of an exploratory approach. Therefore, no 
corrections for multiple testing were applied.
All captured data were analyzed descriptively by appro-
priate statistical parameters: absolute and relative frequen-
cies for categorical data, and arithmetic means and standard 
deviations for numerical data. SPSS (version 22) was used 
for all statistical analyses. More details of the study protocol 
are available elsewhere.16
Results
Sociodemographics and baseline 
characteristics
In six of the study centers, the number of persons enrolled in 
the study varied from 18 to 25. The remaining center brought 
in 37 participants, which necessitated the two IHM groups. 
Of the total of 166 persons, 109 were randomized to the 
intervention group (IHM) and 57 to the control group (UC). 
In the IHM and UC groups, 83 (76.1%) and 40 (70.2%) were 
female, respectively (between-group P=0.457). Mean age 
was 50.1 (SD 9.8) years in the IHM group and 51.6 (SD 9.9) 
years in the UC group (P=0.367). These two groups were 
used for ITT hypothesis testing of the primary outcome – 
body weight.
In four cases, subjects did not receive the treatment to 
which they were randomly allocated (see Figure 1). These 
four subjects received the other intervention by mistake, which 
was not suspected of being manipulated by trial physician or 
participant. As a consequence, 111 subjects received IHM 
and 55 were treated as usual. Comparable to the ITT group, 
age and gender showed no significant differences between the 
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Table 1 Basic sample description and baseline values for secondary outcome parameters
Baseline variable IHM (n=111) UC (n=55) P
Mean SD Mean SD
Age, years 49.9 9.7 52.1 10 0.182
n % n %
Female 83 74.8 40 72.7 0.851
Education
Primary school 29 26.1 14 25.5 0.555
Secondary school 55 49.5 26 47.3
High school 27 24.3 14 25.5
Other 0 1 1.8
Employment status
Employed 90 81.1 44 80 0.392
Occupied without payment 6 5.4 1 1.8
Jobless 2 1.8 1 1.8
Still in education 0 1 1.8
Retired 13 11.7 8 14.5
Living condition
Single household 10 9.1 7 13 0.43
Multiperson household 100 90.9 47 87
Smoker
No 98 88.3 50 90.9 0.792
Yes 13 11.7 5 9.1
•	 If yes, <5 cigarettes per day 3 1
•	 If yes, 5–30 cigarettes per day 10 4
Alcohol consumption
No 61 55 24 43.6 0.189
Yes 50 45 31 56.4
•	 If yes, <1 glass per day 34 21
•	 If yes, 1–2 glasses per day 10 8
•	 If yes, 3–4 glasses per day 1 0
Mean SD Mean SD P
Body weight, kg 89.6 10.2 88.9 11.3 0.681
BMI 31.8 2 31.5 2 0.48
Waist circumference, cm 103.7 8.8 103.2 9.9 0.743
Systolic blood pressure, mmHg 131.4 15.8 134.1 16.7 0.314
Diastolic blood pressure, mmHg 84.3 8.4 85.6 8.7 0.377
Heart rate, beats per min 72.7 10.7 74.7 10.2 0.244
BF, kg 35.5 6.7 35 5.1 0.629
BCM, kg 27.1 5.6 26.9 6.1 0.813
BF:BCM ratio 1.37 0.35 1.36 0.32 0.948
Fasting glucose, mg/dL 92.5 12.9 92.6 11.8 0.959
Total cholesterol, mg/dL 227.6 38 231.1 39.7 0.585
LDL cholesterol, mg/dL 149.3 33.7 150.6 31.3 0.813
HDL cholesterol, mg/dL 58.3 13.3 59.6 15.9 0.587
LDL:HDL ratio 2.73 0.98 2.71 0.9 0.868
Triglycerides, mg/dL 137 76.8 134.5 61.8 0.832
Note: Group allocation “as treated”.
Abbreviations: IHM, Individual Health Management; UC, usual care; SD, standard deviation; BF, body fat; BCM, body cell mass; BMI, body mass index; LDL, low-density 
lipid; HDL, high-density lipid.
groups (Table 1). With respect to education, employment sta-
tus, and smoking and drinking habits, there were no observed 
significant differences between the study groups (Table 1). 
Further, secondary outcome parameters with means and 
standard deviations for both study groups are also presented 
in Table 1. Mean BMI was 31.8 (SD 2) for the IHM group 
and 31.5 (SD 2) for the UC group. There were no statistically 
significant differences between the groups in respect of weight 
and waist circumference, blood pressure, body fat, muscle 
mass, or laboratory findings (Table 1).
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Dropout and protocol violations
As depicted in the consort study flowchart (Figure 1), both 
study groups saw attrition during the 12-month study. Of 111 
subjects who commenced with the IHM group, 17 (15.3%) 
prematurely discontinued the study, while in the UC group 
the dropout rate was 18.2% (10 of 55). The majority of 
dropouts left the study before the control visit at month 3, 
and this occurred in 10 of 17 cases in the IHM group and 
in 9 of 10 in the UC group. The most frequent reasons were 
“overburdened” in the IHM group and “considered not effec-
tive” in the UC group.
The defined preconditions of passing through the whole 
study “per protocol” were fulfilled by 82 and 36 participants 
in the IHM and UC groups, respectively. Those four cases 
with false treatment allocation were not considered per proto-
col. Of the participants of the IHM group with available data 
at month 3, 68% showed 100% adherence to the intervention 
during the first 3 months (participation in two introduction 
days and in all of the 10 after-work meetings). Participation 
rates for the quarterly refresh meetings were 89%–96% of 
the study participants at that time.
Body weight
Based on the ITT population with conservative imputa-
tion of missing values, the main outcome parameter of 
body weight showed a mean decrease of 8.7 kg (SD 6.1, 
n=109) in the intervention group (IHM) and 4.2 kg (SD 
5, n=57) in the control group (UC) at month 12. Weight 
at baseline was 89.5 kg (SD 10.3) in the IHM group and 
89.2 kg (SD 11.1) in the UC group. General linear model 
testing of the change values revealed a highly significant 
difference between the groups (P<0.001). Neither the 
factor “study center” nor the interaction “center × group” 
were statistically signif icant (P=0.101 and P=0.253, 
respectively). The covariate of baseline weight showed a 
statistically significant impact (P=0.033). Therefore, the 
primary null hypothesis of no differences between the 
groups in weight change had to be rejected. Additionally, 
it was shown that in both groups, each weight reduction 
from month 0 to 12 was statistically significant (P<0.001, 
t-test for paired groups).
In the per protocol population, the mean weight reduc-
tion was 10.1 kg (SD 6.2, n=82) in the IHM group and 3 kg 
(SD 3.7, n=36) in the UC group. The mean weight reduction 
from baseline to month 12 was 11% and 2.7% for IHM and 
UC, respectively. The respective figures were 9.9 kg (SD 5.5, 
n=111) and 2.5 kg (SD 3.5, n=55) when groups were ana-
lyzed as treated with realistic imputation of missing values 
at month 12. Without imputation, mean weight reduction 
was 9.9 kg (SD 6, n=94) in the IHM group and 2.4 kg (SD 
3.9, n=45) in the control group (UC). All three sensitivity 
analyses confirmed a statistically significant effect between 
the groups (P<0.001), while showing no significant effects 
of either the factor “center” nor the interaction term “center 
× group”.
The mean course of the quarterly measurements of weight 
is depicted in Figure 3. To avoid the possible impact on mean 
values due to attrition during the study period, only subjects 
with complete data sets (per protocol) were used for this 
analysis. For each sex, the graph shows the most distinct 
weight reduction during the first 3 months, followed by a 
nearly horizontal line, indicating no weight gain toward the 
end of the study. The differences between both intervention 
groups are more pronounced in men.
Sixty-two out of 94 (66.0%) participants in the IHM 
group showed a weight reduction of at least 7.5% of base-
line value at month 12, while this response criterion was 
fulfilled by only 6 of 45 (13.3%) participants in the UC 
group. This difference proved to be statistically significant 
(P<0.001, Fisher’s exact test). Displaying all individual 
pairs of measurements in a scatterplot, it can be demon-
strated that beneficial weight reductions in the IHM group 
were distributed equally across the whole range of baseline 
measures (Figure 4).
The preferred nutritional regimen was fasting in 34%, 
2-day diet in 37%, and meal replacement in 14% of the IHM 
participants; 15% showed a changing diet pattern over time. 
Weight reduction at month 12 was similar in all subgroups, 
presenting mean values of 10.6 kg (SD 6.6), 10.3 kg (SD 5.4), 
7.4 kg (SD 5.5), and 9.3 kg (SD 6.3), respectively.
Month 0
IHM (men, n=20)
UC (women, n=20) IHM (men, n=36)
UC (women, n=62)UC (men, n=11)
IHM (n=82)
70
75
80
85
90
95
100
105
M
ea
n 
w
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gh
t (
kg
)
Month 6Month 3 Month 9 Month 12
Figure 3 Mean weight in both treatment groups during the course of the study, 
separated by gender.
Notes: Thick black lines represent whole-group totals; per protocol subjects only.
Abbreviations: IHM, Individual Health Management; UC, usual care.
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significant changes. However, with respect to these param-
eters, the differences between the groups proved to be sig-
nificantly higher in the IHM group. In addition, the mean 
increase in high-density lipid cholesterol was significantly 
higher under IHM intervention compared to the control 
intervention.  Furthermore, changes in blood pressure, fasting 
glucose, cholesterol, and triglycerides in the IHM group were 
superior to the control group, but failed to reach statistical 
significance. In addition, body composition was analyzed 
separately for men and women. While men showed signifi-
cantly higher means for muscle cell mass at baseline, there 
were no significant interaction effects between treatment 
and sex with respect to pre–post changes in parameters of 
the bioimpedance analysis.
Adverse events
For 101 participants of the IHM group and 46 of the UC 
group, at least one control visit (months 3–12) was carried 
out and documented. Therefore, these groups served as the 
basis for the analysis of AEs. In 36 (35.6%) subjects of the 
IHM group, at least one AE was documented during the 
study, of which 17 were graded as “slight”, 19 as “moder-
ate”, and eight as “strong”. In 23 of these participants, no 
causal relation to the study intervention was given. In seven 
cases, a relation was considered “possible” and “probable” in 
eight cases. Of the control group, in nine (19.6%) subjects at 
least one AE was documented (one slight, five moderate, and 
four strong), with only one having probable relation to the 
intervention. Under IHM intervention with at least possible 
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Figure 4 Scatterplot for weight measurements at months 0 and 12 (without 
imputations).
Notes: Solid line shows diagonal of equal values at both examinations; dashed line 
represents a 7.5% reduction at month 12.
Abbreviations: IHM, Individual Health Management; UC, usual care.
Table 2 Secondary outcome parameter: change from baseline to month 12
Secondary outcome variable IHM (n=94) UC (n=45) Between-group 
difference 
Mean SD Mean SD P
BMI –3.5** 2.15 –0.87** 1.36 <0.001
Waist circumference, cm –11.75** 7.58 –5.26** 5.27 <0.001
Systolic blood pressure, mmHg –5.23** 17.28 0.82 17.67 0.057
Diastolic blood pressure, mmHg –3.23** 9.41 –1.11 11 0.241
Heart rate –2.54* 11.19 –2.84 10.09 0.878
BF, kg –6.73** 5.34# –1.71** 3.59 <0.001
BCM, kg –1.84** 1.7 –0.55 2.16 <0.001
BF:BCM ratio –0.18** 0.19 –0.05* 0.17 <0.001
Fasting glucose, mg/dL –4.8** 13.45§ –1.42 12.34 0.16
Total cholesterol, mg/dL –2.4 28.28# 0.6 35.81 0.594
LDL cholesterol, mg/dL –7.07** 24.10# –2.62 30.06 0.351
HDL cholesterol, mg/dL 5.04** 9.19# 1.6 7.8 0.032
LDL:HDL ratio –0.32** 0.59# –0.14 0.52 0.081
Triglycerides, mg/dL –18.44* 70.81# 1.7 79.34 0.135
Notes: Within group difference between baseline and month 12: *P<0.05; **P<0.01; #n=93; §n=90. Group allocation as treated, without imputation of missing values.
Abbreviations: IHM, Individual Health Management; UC, usual care; SD, standard deviation; BF, body fat; BCM, body cell mass; BMI, body mass index; LDL, low-density 
lipid; HDL, high-density lipid.
Secondary outcome variables
Table 2 shows the mean changes from month 0 to 12 per 
group for all secondary outcomes. In the IHM group, all 
parameters improved significantly, except total cholesterol. 
Under control intervention, only BMI, waist circumference, 
body fat, and ratio of fat and body cell mass presented 
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causality and moderate degree of severity, the following AEs 
were documented: nausea, headache or bad-tempered during 
fasting, panic attacks, joint pain, dry skin, and hair loss. All 
symptoms had completely resolved by the end of the study. 
Three AEs in the IHM group and one in the UC group were 
classified as “severe”. In all, causality by the study interven-
tion was excluded.
Discussion
IHM as a 1-year lifestyle program has clearly proved to 
be superior to standard advice from the doctor in terms of 
weight reduction in people with BMI of 28–35. Based on 
the ITT analysis, a mean decrease of 8.7 kg at month 12 was 
observed in the IHM group, while under UC conditions, the 
mean weight reduction was 4.2 kg. This highly significant 
difference (P<0.001) was achieved, although the primary 
analysis followed a “conservative” approach, implying that 
the imputation technique of missing values, as well as the 
handling of false treatment allocations, favored the control 
group. All sensitivity analyses confirmed the result of the 
primary hypothesis testing, just like that of the subgroup 
of participants who provided complete data sets and suf-
ficient adherence to the lifestyle program, showing weight 
reductions of 10.1 kg and 3 kg for the IHM and UC groups, 
respectively, and thus presenting a more distinct between-
group difference.
The analysis of this multicenter study did not reveal any 
significant center effect, implying that the beneficial effects 
of IHM were similar in all study centers, which is consid-
ered a sign of robustness of the main study results. As such, 
it does not suggest doubts regarding the generalizability of 
the results. Based on a structured IHM concept and also 
provided there exists standardized high-quality educational 
training of the IHM coaches, similar results may be expected 
in other settings.
Research has shown that overweight individuals are 
successful at long-term weight loss when defined as losing 
at least 5%–10% of initial body weight and maintaining the 
loss for at least 1 year.7,17 Guidelines for the management of 
overweight and obesity in adults from the American Heart 
Association suggest that high-intensity comprehensive 
lifestyle programs should achieve average weight losses of 
approximately 8 kg in a 6-month period.7 Christian et al18 
pooled the success rates of various “intense” lifestyle inter-
ventions (13–52 hours of care) and reported weight loss of 
≥10% in 28%, 5%–9.9% in 26%, 0–4.9% in 38%, and no loss/
weight gain in 26% of the participants (percentages do not 
add up to 100% due to the pooling algorithm). When these 
categories are applied to the data of our IHM group, percent-
ages of 49%, 34%, 15%, and 2% are derived, respectively.
Obesity is a lifelong challenge for all persons concerned. 
Beyond weight reduction, maintaining weight loss and 
keeping a healthy weight are the important issues that have 
to be solved from the long-term perspective. In contrast to 
usual patterns of weight loss in people undergoing a lifestyle 
intervention who achieve maximum weight loss at 6 months, 
the graph of our mean weight measurement did not show 
subsequent weight gain over time, but held a plateau in the 
following course of mean weight.17,19 This program adher-
ence might have been due to the individual web-based health 
portal, with some tools for self-monitoring and performance 
measures in order to support participants to monitor weight 
and physical activity continually, and self-reports during their 
1-year program. Findings from the literature indicate that 
daily self-weighing and self-monitoring by a pedometer are 
associated with more distinct weight reduction and decreased 
risk of weight regain.7,14
IHM offered different forms of diet for free choice. The 
most popular nutritional regimens in the present study were 
2-day diet and fasting. However, there were no statistically 
significant differences between mean weight reductions. 
All subgroups with respect to diet form were approximately 
equally effective on weight reduction.20 These results are 
not really surprising, because it is known from other studies 
that in programs for weight reduction, it is more important 
to serve with effective support to adhere to lifestyle changes 
than to provide reputed highly attractive procedures (different 
types of diet).13,21
IHM was also more beneficial in the reduction of blood 
pressure, although just failing statistical significance. Simi-
lar findings were observed in reduction of fasting glucose 
and serum lipids. Increase in high-density lipid cholesterol 
was statistically significant and superior in the IHM group 
compared to the UC group. Bioimpedance analysis showed 
a more pronounced reduction in body fat after IHM, indi-
cating that reduction in body weight was mainly due to 
decreased body fat.22 Unfortunately, weight loss was also 
associated with a decrease in muscle cell mass. However, 
the more pronounced decrement of the ratio of body fat and 
muscle cell mass under IHM elucidates that the reduction in 
fat outweighs the muscle-lowering effect. These beneficial 
findings for IHM were observed similarly in both sexes. 
However, more emphasis should be put on muscle-building 
exercises.23 Lifestyle modification is a key issue with regard 
to risk reduction for diabetes, hypertension, and metabolic 
syndrome.24,25 For such diseases, the positive findings of the 
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TALENT study on weight reduction suggest a preventive 
benefit of IHM.
Strengths and limitations
The study was monitored by a professional institution with 
acknowledged expertise in supervision of clinical trials. The 
monitoring plan comprised central indoor monitoring and on-
site visits at the participating study centers. The monitoring 
reports revealed no serious issues in the on-site conduction 
of the study.
Dropout rates in the IHM and UC groups of 15% and 
18%, respectively, and the fact that about 71% of all study 
participants fulfilled the per protocol criteria demonstrate 
the difficulties in long-term lifestyle intervention studies. 
Nevertheless, our dropout rate was lower than most other 
clinical studies in this field (eg, Weight Watchers – 39%).26 
Although several measures were undertaken to reduce attri-
tion, some IHM participants discontinued the program. Not 
all IHM participants were able to attend all group meetings, 
due to individual requirements of daily life. The variety of all 
these different aspects corresponds to the tenets of IHM as 
an “individualized” way of health management, and thus not 
categorized as experimental bias. In light of these challenges, 
the study was able to accomplish credible and robust findings.
Based on a blended learning concept and using web-based 
e-health tools, the program could provide participants with 
a comprehensive long-term management of overweight and 
obesity and its complications for everyday life over a period 
of at least 1 year. Furthermore, the multicenter study could 
demonstrate that intensive and comprehensive lifestyle 
training can be implemented successfully in local health 
and prophylaxis centers at various health resorts, in order to 
improve the medical quality of their health services.
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